Indication

Diamond Blackfan anemia

Diamond-Blackfan anemia is a rare inherited bone marrow failure syndrome primarily presenting in early infancy or childhood. Read more about Diamond Blackfan anemia

336 drugs 163 manufacturers

Advertisement

Drugs that treat it

Common Diamond Blackfan anemia therapies.

Showing 145–153 of 336 drugs

PREDNISONE

PULMONARY TUBERCULOSIS·+67
Lannett Company

PREDNISONE

PULMONARY TUBERCULOSIS·+67
NOVITIUM PHARMA
Filter & compare in the drug finder →Opens the drug finder with Diamond Blackfan anemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Diamond Blackfan anemia.

Diamond-Blackfan anemia is a rare inherited bone marrow failure syndrome primarily presenting in early infancy or childhood.

It is characterized by pure red cell aplasia, presenting as a profound macrocytic or normochromic anemia with reticulocytopenia and a marked deficiency of erythroid precursors despite an otherwise normocellular bone marrow.

Pathophysiologically, the condition is classified as a ribosomopathy driven predominantly by heterozygous pathogenic variants in ribosomal protein genes, leading to impaired ribosome biogenesis and pro-apoptotic stress during erythropoiesis.

Up to half of affected individuals demonstrate associated physical anomalies, such as craniofacial, upper limb, cardiac, or urogenital malformations, as well as an increased predisposition to myelodysplastic syndrome, acute myeloid leukemia, and solid tumors.

Personalize your experience

Follow Diamond Blackfan anemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it